JANUS HENDERSON GROUP PLC - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 235 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
JANUS HENDERSON GROUP PLC ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$569,140
+0.6%
80,443
+0.0%
0.00%
Q2 2023$565,873
-15.8%
80,436
-0.1%
0.00%
Q1 2023$671,951
-97.1%
80,522
-96.1%
0.00%
-100.0%
Q4 2022$23,529,643
+5089.0%
2,050,026
+2749.0%
0.02%
Q3 2022$453,453
+19.3%
71,956
+100.4%
0.00%
Q2 2022$380,000
-34.9%
35,901
-0.1%
0.00%
Q1 2022$584,000
+17.3%
35,931
+0.0%
0.00%
Q4 2021$498,000
+93.8%
35,922
+101.2%
0.00%
Q3 2021$257,000
-97.4%
17,854
-99.6%
0.00%
-100.0%
Q1 2020$9,755,000
-69.9%
4,877,731
-48.2%
0.01%
-58.8%
Q4 2019$32,459,000
+19.0%
9,408,481
-1.2%
0.02%
+13.3%
Q3 2019$27,276,000
-25.0%
9,520,564
-0.8%
0.02%
-25.0%
Q2 2019$36,370,000
-63.5%
9,596,344
-21.7%
0.02%
-63.6%
Q1 2019$99,776,000
+0.5%
12,257,442
-0.4%
0.06%
-12.7%
Q4 2018$99,282,000
+6.2%
12,302,555
+0.4%
0.06%
+26.0%
Q3 2018$93,469,000
+47.0%
12,250,161
+10.4%
0.05%
+38.9%
Q2 2018$63,581,000
+74.1%
11,096,183
+45.0%
0.04%
+63.6%
Q1 2018$36,513,000
+10.3%
7,654,685
+13.6%
0.02%
+10.0%
Q4 2017$33,090,000
+39.3%
6,739,266
+48.6%
0.02%
+33.3%
Q3 2017$23,762,0004,534,7270.02%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Burrage Capital Management LLC 1,105,673$8,237,0006.28%
Sarissa Capital Management LP 8,175,000$60,903,0006.22%
ORACLE INVESTMENT MANAGEMENT INC 2,980,870$22,207,0002.78%
DG Capital Management, LLC 1,075,732$8,014,0001.70%
Ghost Tree Capital, LLC 900,000$6,705,0001.49%
Parkman Healthcare Partners LLC 538,370$4,011,0001.03%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,835,810$43,477,0000.86%
Formidable Asset Management, LLC 470,419$3,470,0000.80%
KNOTT DAVID M 219,461$1,635,0000.74%
Altium Capital Management LP 250,000$1,863,0000.70%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders